Browse All

Current Filters

CLEAR FILTER x

TITLE

Clinical Profile for Lecanemab Subcutaneous Formulation for Treatment Initiation and Maintenance in Early Alzheimer’s Disease (AD)

Effects of Oral Valiltramiprosate on Clinical Efficacy, Safety, and Brain Volume Outcomes in APOE4/4 Homozygotes with Early Alzheimer’s Disease (AD): Topline Results of the 78-week Phase 3 APOLLOE4 Trial

Associations Between Continuing Medical Education Participation and Real-world Readiness for Amyloid-targeting Therapies in Alzheimer’s Disease